Ro vs. Hims vs. WeightWatchers: The Three-Way Telehealth Verdict

Something remarkable happened in March 2026: Novo Nordisk unified GLP-1 pricing across three of the biggest telehealth brands in America. Ro, WeightWatchers, and LifeMD launched the Wegovy subscription on March 31. Hims & Hers followed within weeks (after ending a legal dispute with Novo over copycat products). Sesame joined shortly after.

The upshot: whether you subscribe to Ro, Hims, or WeightWatchers, you pay the same $249/month on a 12-month Wegovy plan. Same FDA-approved medication. Same pen. Same delivery.

So the question moved from "Where's Wegovy cheapest?" to "Which platform is the right fit?" That's a different — and more interesting — question.

The pricing is now the same. Here's the proof.

All three also sell compounded semaglutide at similar-to-identical prices (typically $199–229/mo), and all three now require separate membership fees on top of medication costs. Since the commodity (Wegovy) is identical everywhere, the differentiation is in the service.

Ro: the clinical operator

Ro started as a men's sexual-health telehealth company and evolved into a full-stack clinical platform. It's the most medical of the three — meaning Ro's consultation flow, dose titration protocols, and follow-up cadence feel the most like a traditional doctor visit ported to your phone.

What Ro does well

• Fast prescription turnaround. Most Ro patients get a prescription decision within 24 hours of intake, often same day.
• Strong provider network. Ro uses employed clinicians rather than contract-only providers, so continuity of care is better.
• Multi-service integration. If you're already on Ro for another medication (testosterone, hair loss, ED), adding Wegovy is seamless.
• Zach Reitano, Ro's CEO, partnered directly with Novo Nordisk to help design the subscription program. Ro was a launch platform.

Where Ro falls short

• Light behavior-change and coaching support compared to WeightWatchers.
• Membership fee adds to the total cost (not included in $249 medication price).
• Less well-known to users who haven't used telehealth before.

Hims & Hers: the consumer brand

Hims & Hers is the largest direct-to-consumer telehealth company in the US by revenue. It's the brand your cousin has seen on TikTok. It has mass-market distribution, a polished app, and — as of March 2026 — a first-class Novo Nordisk partnership that resolved its earlier conflict over selling compounded knockoffs.

What Hims does well

• Best mobile-first experience. The Hims/Hers app is the most polished of the three. If you do everything on your phone, it shows.
• Massive brand recognition. If friends or family ask "what platform are you using?", Hims is the least-explanation-required answer.
• Full body wellness stack. Skin, hair, mental health, and weight loss under one membership if you want it.
• Now sells FDA-approved Wegovy at subscription prices, in addition to its compounded offerings.

Where Hims falls short

• Clinical care is lighter than Ro. Intake and follow-ups feel more like filling out a form than talking to a doctor.
• The 2025 legal battle with Novo over compounded products left some customer confusion about what Hims actually sells. Worth verifying at checkout.
• Mixed customer service reputation — great when it works, hard to resolve when it doesn't.

WeightWatchers: the behavior-change platform

WeightWatchers reinvented itself as WeightWatchers Clinic (now "WeightWatchers Med+") after the rise of GLP-1 medications threatened its core points-tracking business. The pivot worked. Today, WeightWatchers Med+ is the only major GLP-1 platform built around weight loss specifically, not general telehealth.

What WeightWatchers does well

• Integrated coaching and nutrition. This is where WW crushes both competitors. If you believe long-term weight loss needs behavior change + medication (research strongly suggests it does), WW is the only platform designed around that principle.
• $25 first-month intro for the Med+ membership (12-month commitment required for that rate).
• 50-year weight management heritage. Trustworthy, established, not a startup.
• Insurance coordination. WW is one of the few platforms that actively pursues prior authorizations and insurance coverage rather than defaulting to cash-pay.

Where WeightWatchers falls short

• Medication costs are separate from the subscription, which can be confusing upfront.
• Less flexibility for non-weight-loss concerns. If you also want testosterone or hair loss, you'll need a second platform.
• The transition from "diet company" to "medical company" isn't fully complete in every customer interaction.

Who should pick which

The compounded question

All three also sell compounded semaglutide, typically at $179–229/month. If you want compounded instead of Wegovy, the same platform-choice logic applies — but with one caveat.

The hidden cost: membership fees

The $249/month Wegovy price is the medication only. All three platforms charge a separate membership or care fee:

• Ro: Medication visit fees and optional membership bundles. Total annual cost typically $249/mo × 12 + ~$100–300 annual platform fees.
• Hims & Hers: Membership rolled into service costs. Similar effective annual total to Ro.
• WeightWatchers Med+: $25 first month, varies after. Annual membership can add $300–500 on top of medication.

Budget for ~$3,200–3,500 per year all-in for any of the three platforms at the 12-month Wegovy rate. That's still a massive improvement over the $5,988 annual cost at pre-November 2025 Wegovy pricing.

Our pick for April 2026

If we had to pick one and force everyone onto the same platform: WeightWatchers Med+, for the behavior-change integration. The research on weight-loss maintenance strongly favors combining medication with lifestyle support, and WW is the only one of the three built around that model.

But this isn't a one-size-fits-all decision. Ro is genuinely better for speed and clinical depth. Hims is genuinely better if you want the most polished app experience and don't need heavy clinical touch. Pick based on how you actually engage with healthcare, not on which brand you recognize.

Alternative: skip all three and go direct

One option we rarely see discussed: if you want brand-name Wegovy and already have a primary care physician, ask them for a prescription and fill it at Costco, GoodRx, or NovoCare directly. All three honor the $349 cash-pay price. You skip the telehealth membership fee entirely.

This only works if your PCP will prescribe GLP-1s for weight loss (many still won't without a specialist referral), but it's the cheapest path if it works for you.

Bottom line

Ro, Hims, and WeightWatchers stopped competing on Wegovy price the moment Novo Nordisk made them all offer $249/month. They're now competing on platform, coaching, brand, and clinical experience. Decide what you need around the medication — then pick accordingly. There's no wrong answer here, only different ones.